chr13-37583283-A-T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_006475.3(POSTN):c.1243+686T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0913 in 152,062 control chromosomes in the GnomAD database, including 796 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.091   (  796   hom.,  cov: 32) 
Consequence
 POSTN
NM_006475.3 intron
NM_006475.3 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  0.472  
Publications
1 publications found 
Genes affected
 POSTN  (HGNC:16953):  (periostin) This gene encodes a secreted extracellular matrix protein that functions in tissue development and regeneration, including wound healing, and ventricular remodeling following myocardial infarction. The encoded protein binds to integrins to support adhesion and migration of epithelial cells. This protein plays a role in cancer stem cell maintenance and metastasis. Mice lacking this gene exhibit cardiac valve disease, and skeletal and dental defects. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Sep 2015] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64). 
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.141  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| POSTN | NM_006475.3 | c.1243+686T>A | intron_variant | Intron 9 of 22 | ENST00000379747.9 | NP_006466.2 | 
Ensembl
Frequencies
GnomAD3 genomes  0.0913  AC: 13872AN: 151944Hom.:  795  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
13872
AN: 
151944
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  0.0913  AC: 13882AN: 152062Hom.:  796  Cov.: 32 AF XY:  0.0925  AC XY: 6880AN XY: 74346 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
13882
AN: 
152062
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
6880
AN XY: 
74346
show subpopulations 
African (AFR) 
 AF: 
AC: 
5798
AN: 
41466
American (AMR) 
 AF: 
AC: 
2229
AN: 
15262
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
248
AN: 
3466
East Asian (EAS) 
 AF: 
AC: 
367
AN: 
5172
South Asian (SAS) 
 AF: 
AC: 
299
AN: 
4816
European-Finnish (FIN) 
 AF: 
AC: 
808
AN: 
10564
Middle Eastern (MID) 
 AF: 
AC: 
35
AN: 
292
European-Non Finnish (NFE) 
 AF: 
AC: 
3863
AN: 
68006
Other (OTH) 
 AF: 
AC: 
199
AN: 
2106
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.504 
Heterozygous variant carriers
 0 
 612 
 1224 
 1835 
 2447 
 3059 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 142 
 284 
 426 
 568 
 710 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
220
AN: 
3468
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.